Tag: iSonea

Posted on

iSonea rapidly approaches commercialisation, targets US$16 billion asthma market – Proactive Investors UK


mobihealthnews

iSonea rapidly approaches commercialisation, targets US$16 billion asthma market
Proactive Investors UK
iSonea (ASX: ISN) is preparing to roll out a number of its asthma products over the next 24 months after entering its first formal partnership with telecommunications company Qualcomm Life for the development of a mobile asthma monitoring platform.
iSonea to Develop New Asthma Mobile Health Technology Based on Qualcomm 2net HubMarketWatch (press release)
Qualcomm Life, iSonea to offer mobile asthma monitormobihealthnews
iSonea gains partner to develop new mobile asthma monitoring systemProactive Investors USA & Canada

all 15 news articles »

View full post on asthma – Google News

Posted on

Qualcomm Life, iSonea to offer mobile asthma monitor – mobihealthnews


mobihealthnews

Qualcomm Life, iSonea to offer mobile asthma monitor
mobihealthnews
Annapolis, Maryland-based asthma monitoring technology company iSonea has inked a deal with Qualcomm Life, a subsidiary of Qualcomm, to combine iSonea's proprietary Acoustic Respiratory Monitoring (ARM) devices and forthcoming mobile health asthma …
iSonea to Develop New Asthma Mobile Health Technology Based on Qualcomm 2net HubMarketWatch (press release)
iSonea gains partner to develop new mobile asthma monitoring systemProactive Investors UK

all 11 news articles »

View full post on asthma – Google News

Posted on

iSonea gains partner to develop new mobile asthma monitoring system – Proactive Investors Australia

iSonea gains partner to develop new mobile asthma monitoring system
Proactive Investors Australia
They are focused on pulmonary acoustics as diagnostic and monitoring tools for managing asthma. iSonea is a step closer to achieving a core objective of its commercialisation plan of developing over-the-counter asthma monitoring devices with mobile …

View full post on asthma – Google News

Posted on

iSonea launches into US market with American Depositary Receipts – Proactive Investors Australia


Proactive Investors Australia

iSonea launches into US market with American Depositary Receipts
Proactive Investors Australia
Medical technology company iSonea is focused on developing innovative monitoring systems and software for the management of asthma. The company is currently working on the development and launch of the first Acoustic Respiratory Monitoring devices, …
iSonea rights issues provides better than expected return of A$4.6mProactive Investors USA & Canada

all 4 news articles »

View full post on asthma – Google News

Posted on

iSonea Limited Joins OTCQX – Sacramento Bee

iSonea Limited Joins OTCQX
Sacramento Bee
iSonea manufactures medical devices for the monitoring and management of breathing disorders, particularly related to asthma, sleep apnea and chronic obstructive pulmonary disease. The company's devices use proprietary acoustic sensors to listen to the …
iSonea Limited Commences Trading on the U.S. OTCQX InternationalMarketWatch (press release)

all 21 news articles »

View full post on asthma – Google News

Posted on

iSonea to commercialise asthma monitoring devices – Electronics News

iSonea to commercialise asthma monitoring devices
Electronics News
ISONEA says it is focusing on the commercialisation of its over-the-counter asthma monitoring devices which will work with mobile health apps. iSonea is the joint effort of Israel-based iSonea and Australian company …
iSonea accelerates commercialisation of asthma devices in US, in negotiations …Proactive Investors Australia
iSonea ramps up product effortsAustralian Life Scientist
iSonea accelerates commercialisation of asthma devices in U.S., in …Proactive Investors UK

all 5 news articles »

View full post on asthma – Google News

Posted on

iSonea accelerates commercialisation of asthma devices in US, in negotiations … – Proactive Investors Australia

iSonea accelerates commercialisation of asthma devices in US, in negotiations …
Proactive Investors Australia
They are focused on pulmonary acoustics as diagnostic and monitoring tools for managing asthma. iSonea is currently in negotiations with major strategic partners to accelerate commercialisation and cash flows of its next generation asthma products in …

View full post on asthma – Google News